Workshop I Panel Discussion - Approaches to Developing an Enhanced Understanding of Product Quality Expectations
Date
January 27, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Additional Panelist: Douglas Roepke, Eli Lilly and Company
Session Chairs
General
Related Products
Parallel Session 2B- LER 2025: Strategies Today for Overcoming Low Endotoxin Recovery
Monitoring and control of endotoxin are critical aspects of an overall microbial control strategy necessary to ensure drug product quality and patient safety…
Turning Mandates into Momentum: How CASSS Can Help Sonia Vallabh?
As a follow-up to Tuesday's very impactful Keynote presentation, join us in-person or online as we come together as a community and brainstorm ways to further Sonia's mission to prevent prion disease…
Keynote Presentation - The Road to Preventing Prion Disease: Opportunities, Challenges, and My Personal Mandate
Keynote Speaker: Sonia Vallabh, Ph.D…
CASSS Welcome and CMC Strategy Forum 2025 Introductory Comments & Workshop I - Approaches to Developing an Enhanced Understanding of Product Quality Expectations
Forum Co-Chairs: Fiona Cornel, _Health Canada, _JR Dobbins, _Eli Lilly and Company,_ Doug Richardson,_ Merck & Company, Inc…
